Release Date: 20/10/14 17:27 Summary: Quarterly Cashflow Report Price Sensitive: Yes Download Document 203.38KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%